Lista de obras -

A diagnostics platform for the integrated mapping, monitoring, and surveillance of neglected tropical diseases: rationale and target product profiles

artículo científico publicado en 2012

A schistosomiasis research agenda

artículo científico publicado en 2007

Association of the gene polymorphisms IFN-gamma +874, IL-13 -1055 and IL-4 -590 with patterns of reinfection with Schistosoma mansoni

artículo científico publicado en 2009

Associations between schistosomiasis and HIV-1 acquisition risk in four prospective cohorts: a nested case-control analysis

artículo científico publicado en 2020

Author Correction: Microbiota therapy acts via a regulatory T cell MyD88/RORγt pathway to suppress food allergy

artículo científico publicado en 2019

Circulating Anodic Antigen (CAA): A Highly Sensitive Diagnostic Biomarker to Detect Active Schistosoma Infections-Improvement and Use during SCORE

scientific article published on 12 May 2020

Circulating CD23+ B cell subset correlates with the development of resistance to Schistosoma mansoni reinfection in occupationally exposed adults who have undergone multiple treatments

artículo científico publicado en 2009

Cluster randomized trial comparing school-based mass drug administration schedules in areas of western Kenya with moderate initial prevalence of Schistosoma mansoni infections.

artículo científico publicado en 2017

Correlation between eosinophils and protection against reinfection with Schistosoma mansoni and the effect of human immunodeficiency virus type 1 coinfection in humans

artículo científico publicado en 2006

Early lessons from schistosomiasis mass drug administration programs

artículo científico publicado en 2015

Eliminating lymphatic filariasis, onchocerciasis, and schistosomiasis from the americas: breaking a historical legacy of slavery

artículo científico publicado en 2007

Evaluation, Validation, and Recognition of the Point-of-Care Circulating Cathodic Antigen, Urine-Based Assay for Mapping Schistosoma mansoni Infections

scientific article published on 12 May 2020

Five-Year Impact of Different Multi-Year Mass Drug Administration Strategies on Childhood Schistosoma mansoni-Associated Morbidity: A Combined Analysis from the Schistosomiasis Consortium for Operational Research and Evaluation Cohort Studies in the

scientific article published on 01 December 2019

Functional Studies of T Regulatory Lymphocytes in Human Schistosomiasis in Western Kenya.

artículo científico publicado en 2018

Gaining and sustaining schistosomiasis control: study protocol and baseline data prior to different treatment strategies in five African countries

artículo científico publicado en 2016

Genetic diversity of Trichomonas vaginalis clinical isolates determined by EcoRI restriction fragment length polymorphism of heat-shock protein 70 genes.

scientific article published on February 2009

Geographic distribution of schistosomiasis and soil-transmitted helminths in Western Kenya: implications for anthelminthic mass treatment.

artículo científico publicado en 2003

High prevalence of schistosomiasis in Mbita and its adjacent islands of Lake Victoria, western Kenya ⬇️

artículo científico publicado el 3 de diciembre de 2012

Higher percentages of circulating mast cell precursors correlate with susceptibility to reinfection with Schistosoma mansoni

artículo científico publicado en 2006

Identification of Cytokeratin 18 as a Biomarker of Mouse and Human Hepatosplenic Schistosomiasis ⬇️

artículo científico publicado el 28 de febrero de 2011

Idiotypes expressed early in experimental Schistosoma mansoni infections predict clinical outcomes of chronic disease

artículo científico publicado en 2002

Immunology of human schistosomiasis

artículo científico publicado en 2014

Immunoregulation and World Health Assembly resolution 54.19: why does treatment control morbidity?

artículo científico publicado en 2004

Impact of Different Mass Drug Administration Strategies for Gaining and Sustaining Control of Schistosoma mansoni and Schistosoma haematobium Infection in Africa

scientific article published on 12 May 2020

Impact of Four Years of Annual Mass Drug Administration on Prevalence and Intensity of Schistosomiasis among Primary and High School Children in Western Kenya: A Repeated Cross-Sectional Study

artículo científico publicado en 2018

Impact of Mothers' Schistosomiasis Status During Gestation on Children's IgG Antibody Responses to Routine Vaccines 2 Years Later and Anti-Schistosome and Anti-Malarial Responses by Neonates in Western Kenya.

artículo científico publicado en 2018

Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya

artículo científico publicado en 2009

Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni

artículo científico publicado en 2010

Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoni

artículo científico publicado en 2010

Interactions between schistosomiasis and human immunodeficiency virus in Western Kenya

artículo científico publicado en 2004

Lessons Learned in Conducting Mass Drug Administration for Schistosomiasis Control and Measuring Coverage in an Operational Research Setting

scientific article published on 12 May 2020

Microbiota therapy acts via a regulatory T cell MyD88/RORγt pathway to suppress food allergy

artículo científico publicado en 2019

Osteopontin Is Upregulated in Human and Murine Acute Schistosomiasis Mansoni

artículo científico publicado en 2016

Persistent Hotspots in Schistosomiasis Consortium for Operational Research and Evaluation Studies for Gaining and Sustaining Control of Schistosomiasis after Four Years of Mass Drug Administration of Praziquantel

scientific article published on 01 September 2019

Proteomic changes at 8weeks after infection are associated with chronic liver pathology in experimental schistosomiasis ⬇️

artículo científico publicado el 10 de enero de 2012

Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries

artículo científico publicado en 2017

Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni

artículo científico publicado en 2009

Resistance to reinfection with Schistosoma mansoni in occupationally exposed adults and effect of HIV-1 co-infection on susceptibility to schistosomiasis: a longitudinal study

artículo científico publicado en 2002

SCORE Studies on the Impact of Drug Treatment on Morbidity due to Schistosoma mansoni and Schistosoma haematobium Infection

scientific article published on 12 May 2020

Schistosomiasis Induces Persistent DNA Methylation and Tuberculosis-Specific Immune Changes

artículo científico publicado en 2018

Schistosomiasis in Africa: Improving strategies for long-term and sustainable morbidity control.

artículo científico publicado en 2018

Serum osteopontin is a biomarker of severe fibrosis and portal hypertension in human and murine schistosomiasis mansoni

artículo científico publicado en 2016

Short report: Childhood coinfections with Plasmodium falciparum and Schistosoma mansoni result in lower percentages of activated T cells and T regulatory memory cells than schistosomiasis only.

artículo científico publicado en 2009

Short report: Evaluation of hepatic fibrosis in persons co-infected with Schistosoma mansoni and human immunodeficiency virus 1.

artículo científico publicado en 2004

Survey of Schistosomiasis in Saint Lucia: Evidence for Interruption of Transmission

artículo científico publicado en 2020

T regulatory cell levels decrease in people infected with Schistosoma mansoni on effective treatment

artículo científico publicado en 2007

Water-based interventions for schistosomiasis control

artículo científico publicado en 2014

When Should the Emphasis on Schistosomiasis Control Move to Elimination?

artículo científico publicado en 2018

Young Adults in Endemic Areas: An Untreated Group in Need of School-Based Preventive Chemotherapy for Schistosomiasis Control and Elimination

artículo científico publicado en 2018

Lista de obras de

A diagnostics platform for the integrated mapping, monitoring, and surveillance of neglected tropical diseases: rationale and target product profiles

A schistosomiasis research agenda

Association of the gene polymorphisms IFN-gamma +874, IL-13 -1055 and IL-4 -590 with patterns of reinfection with Schistosoma mansoni

Associations between schistosomiasis and HIV-1 acquisition risk in four prospective cohorts: a nested case-control analysis

Author Correction: Microbiota therapy acts via a regulatory T cell MyD88/RORγt pathway to suppress food allergy

Circulating Anodic Antigen (CAA): A Highly Sensitive Diagnostic Biomarker to Detect Active Schistosoma Infections-Improvement and Use during SCORE

Circulating CD23+ B cell subset correlates with the development of resistance to Schistosoma mansoni reinfection in occupationally exposed adults who have undergone multiple treatments

Cluster randomized trial comparing school-based mass drug administration schedules in areas of western Kenya with moderate initial prevalence of Schistosoma mansoni infections.

Correlation between eosinophils and protection against reinfection with Schistosoma mansoni and the effect of human immunodeficiency virus type 1 coinfection in humans

Early lessons from schistosomiasis mass drug administration programs

Eliminating lymphatic filariasis, onchocerciasis, and schistosomiasis from the americas: breaking a historical legacy of slavery

Evaluation, Validation, and Recognition of the Point-of-Care Circulating Cathodic Antigen, Urine-Based Assay for Mapping Schistosoma mansoni Infections

Five-Year Impact of Different Multi-Year Mass Drug Administration Strategies on Childhood Schistosoma mansoni-Associated Morbidity: A Combined Analysis from the Schistosomiasis Consortium for Operational Research and Evaluation Cohort Studies in the

Functional Studies of T Regulatory Lymphocytes in Human Schistosomiasis in Western Kenya.

Gaining and sustaining schistosomiasis control: study protocol and baseline data prior to different treatment strategies in five African countries

Genetic diversity of Trichomonas vaginalis clinical isolates determined by EcoRI restriction fragment length polymorphism of heat-shock protein 70 genes.

Geographic distribution of schistosomiasis and soil-transmitted helminths in Western Kenya: implications for anthelminthic mass treatment.

High prevalence of schistosomiasis in Mbita and its adjacent islands of Lake Victoria, western Kenya ⬇️

Higher percentages of circulating mast cell precursors correlate with susceptibility to reinfection with Schistosoma mansoni

Identification of Cytokeratin 18 as a Biomarker of Mouse and Human Hepatosplenic Schistosomiasis ⬇️

Idiotypes expressed early in experimental Schistosoma mansoni infections predict clinical outcomes of chronic disease

Immunology of human schistosomiasis

Immunoregulation and World Health Assembly resolution 54.19: why does treatment control morbidity?

Impact of Different Mass Drug Administration Strategies for Gaining and Sustaining Control of Schistosoma mansoni and Schistosoma haematobium Infection in Africa

Impact of Four Years of Annual Mass Drug Administration on Prevalence and Intensity of Schistosomiasis among Primary and High School Children in Western Kenya: A Repeated Cross-Sectional Study

Impact of Mothers' Schistosomiasis Status During Gestation on Children's IgG Antibody Responses to Routine Vaccines 2 Years Later and Anti-Schistosome and Anti-Malarial Responses by Neonates in Western Kenya.

Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya

Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni

Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoni

Interactions between schistosomiasis and human immunodeficiency virus in Western Kenya

Lessons Learned in Conducting Mass Drug Administration for Schistosomiasis Control and Measuring Coverage in an Operational Research Setting

Microbiota therapy acts via a regulatory T cell MyD88/RORγt pathway to suppress food allergy

Osteopontin Is Upregulated in Human and Murine Acute Schistosomiasis Mansoni

Persistent Hotspots in Schistosomiasis Consortium for Operational Research and Evaluation Studies for Gaining and Sustaining Control of Schistosomiasis after Four Years of Mass Drug Administration of Praziquantel

Proteomic changes at 8weeks after infection are associated with chronic liver pathology in experimental schistosomiasis ⬇️

Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries

Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni

Resistance to reinfection with Schistosoma mansoni in occupationally exposed adults and effect of HIV-1 co-infection on susceptibility to schistosomiasis: a longitudinal study

SCORE Studies on the Impact of Drug Treatment on Morbidity due to Schistosoma mansoni and Schistosoma haematobium Infection

Schistosomiasis Induces Persistent DNA Methylation and Tuberculosis-Specific Immune Changes

Schistosomiasis in Africa: Improving strategies for long-term and sustainable morbidity control.

Serum osteopontin is a biomarker of severe fibrosis and portal hypertension in human and murine schistosomiasis mansoni

Short report: Childhood coinfections with Plasmodium falciparum and Schistosoma mansoni result in lower percentages of activated T cells and T regulatory memory cells than schistosomiasis only.

Short report: Evaluation of hepatic fibrosis in persons co-infected with Schistosoma mansoni and human immunodeficiency virus 1.

Survey of Schistosomiasis in Saint Lucia: Evidence for Interruption of Transmission

T regulatory cell levels decrease in people infected with Schistosoma mansoni on effective treatment

Water-based interventions for schistosomiasis control

When Should the Emphasis on Schistosomiasis Control Move to Elimination?

Young Adults in Endemic Areas: An Untreated Group in Need of School-Based Preventive Chemotherapy for Schistosomiasis Control and Elimination